These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 7505049)
1. Hepatocellular carcinoma in the very elderly: to treat or not to treat? Arbaje YM; Carbone PP Med Pediatr Oncol; 1994; 22(2):84-7. PubMed ID: 7505049 [TBL] [Abstract][Full Text] [Related]
2. Education and Imaging. Hepatobiliary and Pancreatic: Complete remission after hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with decompensated cirrhosis. Seo JH; Song MJ J Gastroenterol Hepatol; 2016 Jan; 31(1):10. PubMed ID: 26177574 [No Abstract] [Full Text] [Related]
4. Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study. Itokawa N; Atsukawa M; Tsubota A; Okubo T; Arai T; Nakagawa A; Kondo C; Iwakiri K Int J Clin Oncol; 2016 Aug; 21(4):676-683. PubMed ID: 26701173 [TBL] [Abstract][Full Text] [Related]
5. Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy. Akçali Z; Akin E; Ozyilkan O Cancer; 2002 Nov; 95(9):2038-9; author reply 2039. PubMed ID: 12404300 [No Abstract] [Full Text] [Related]
6. Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Chung YH; Song IH; Song BC; Lee GC; Koh MS; Yoon HK; Lee YS; Sung KB; Suh DJ Cancer; 2000 May; 88(9):1986-91. PubMed ID: 10813709 [TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy in the treatment of hepatoblastoma. Staines A; Cullen S; Guiney EJ; Fitzgerald RJ; Breatnach F Pediatr Hematol Oncol; 1990; 7(2):205-7. PubMed ID: 1698434 [No Abstract] [Full Text] [Related]
8. A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Ando E; Yamashita F; Tanaka M; Tanikawa K Cancer; 1997 May; 79(10):1890-6. PubMed ID: 9149014 [TBL] [Abstract][Full Text] [Related]
9. Combined cis-platinum and alpha interferon therapy of advanced hepatocellular carcinoma. Ji SK; Park NH; Choi HM; Kim YW; Lee SH; Lee KH; Ahn SY; Lee SU; Han BH; Park BC Korean J Intern Med; 1996 Jan; 11(1):58-68. PubMed ID: 8882477 [TBL] [Abstract][Full Text] [Related]
10. A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. Yeo W; Mok TS; Zee B; Leung TW; Lai PB; Lau WY; Koh J; Mo FK; Yu SC; Chan AT; Hui P; Ma B; Lam KC; Ho WM; Wong HT; Tang A; Johnson PJ J Natl Cancer Inst; 2005 Oct; 97(20):1532-8. PubMed ID: 16234567 [TBL] [Abstract][Full Text] [Related]
11. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis. Eun JR; Lee HJ; Moon HJ; Kim TN; Kim JW; Chang JC Scand J Gastroenterol; 2009; 44(12):1477-86. PubMed ID: 19958061 [TBL] [Abstract][Full Text] [Related]
12. [The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma]. Noda T; Nagano H; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Ohsuga K; Kim T; Tomoda K; Nakamura H; Monden M Gan To Kagaku Ryoho; 2006 Sep; 33(9):1221-5. PubMed ID: 16969014 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of early response to hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma using the combination of response evaluation criteria in solid tumors and tumor markers. Miyaki D; Kawaoka T; Aikata H; Kan H; Fujino H; Fukuhara T; Kobayashi T; Naeshiro N; Honda Y; Tsuge M; Hiramatsu A; Imamura M; Hyogo H; Kawakami Y; Yoshimatsu R; Yamagami T; Awai K; Chayama K J Gastroenterol Hepatol; 2015 Apr; 30(4):726-32. PubMed ID: 25311578 [TBL] [Abstract][Full Text] [Related]